FOLH1 and prostate carcinoma: A dependence between the average number of RIF per cell at time points > 24 h after administration and the dose rate was shown in a previous study in prostate cancer patients during therapy with [177Lu]Lu-PSMA [12] and also tested here, including all data points for t ≥ 20 h.